Literature DB >> 33503199

Updated birth prevalence and relative frequency of mucopolysaccharidoses across Brazilian regions.

Juliana Alves Josahkian1,2, Franciele Barbosa Trapp3,4,5, Maira Graeff Burin3,4,5, Kristiane Michelin-Tirelli3,4,5, Ana Paula Pereira Scholz de Magalhães3,4,5, Fernanda Medeiros Sebastião3,4,5, Fernanda Bender3,4,5, Jurema Fátima De Mari3,4, Ana Carolina Brusius-Facchin3,4,5, Sandra Leistner-Segal3,4,5, Diana Rojas Málaga6, Roberto Giugliani2,3,4,5,7,8,9.   

Abstract

The mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by 11 enzyme deficiencies, classified into seven types. Data on the birth prevalence of each MPS type are available for only a few countries, and the totality of cases may be underestimated. To determine the epidemiological profile of MPS in each Brazilian region, we analyzed data collected between 1982 and 2019 by a national reference laboratory and identified 1,652 patients. Using data between 1994 and 2018, the birth prevalence (by 100,000 live births) for MPS was 1.57. MPS II was the most common type of MPS in Brazil, and its birth prevalence was 0.48 (0.94 considering only male births). Regarding the number of cases per region, MPS II was the most frequent in the North and Center-West (followed by MPS VI), and also in the Southeast (followed by MPS I); MPS I and MPS II were the most common types in the South; and MPS VI was the most common in the Northeast (followed by MPS II). The differences observed in the relative frequencies of MPS types across Brazilian regions are likely linked to founder effect, endogamy, and consanguinity, but other factors may be present and need further investigation.

Entities:  

Year:  2021        PMID: 33503199      PMCID: PMC7839630          DOI: 10.1590/1678-4685-GMB-2020-0138

Source DB:  PubMed          Journal:  Genet Mol Biol        ISSN: 1415-4757            Impact factor:   1.771


  15 in total

Review 1.  An overview of Korean patients with mucopolysaccharidosis and collaboration through the Asia Pacific MPS Network.

Authors:  Sung Yoon Cho; Young Bae Sohn; Dong-Kyu Jin
Journal:  Intractable Rare Dis Res       Date:  2014-08

2.  Mucopolysaccharidosis type II: identification of 30 novel mutations among Latin American patients.

Authors:  A C Brusius-Facchin; I V D Schwartz; C Zimmer; M G Ribeiro; A X Acosta; D Horovitz; I L Monlleó; M I B Fontes; A Fett-Conte; R P Oliveira Sobrinho; A R Duarte; R Boy; P Mabe; M Ascurra; M de Michelena; K L Tylee; G T N Besley; M C V Garreton; R Giugliani; S Leistner-Segal
Journal:  Mol Genet Metab       Date:  2013-09-01       Impact factor: 4.797

3.  Estimated birth prevalence of mucopolysaccharidoses in Brazil.

Authors:  Andressa Federhen; Gabriela Pasqualim; Talita Freitas de Freitas; Esteban Alberto Gonzalez; Franciele Trapp; Ursula Matte; Roberto Giugliani
Journal:  Am J Med Genet A       Date:  2020-01-11       Impact factor: 2.802

4.  Epidemiology of mucopolysaccharidoses.

Authors:  Shaukat A Khan; Hira Peracha; Diana Ballhausen; Alfred Wiesbauer; Marianne Rohrbach; Matthias Gautschi; Robert W Mason; Roberto Giugliani; Yasuyuki Suzuki; Kenji E Orii; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2017-05-26       Impact factor: 4.797

Review 5.  [Mucopolysaccharidosis: clinical features, diagnosis and management].

Authors:  Jorge Luis Suarez-Guerrero; Pedro José Iván Gómez Higuera; Juan Sebastian Arias Flórez; Gustavo Adolfo Contreras-García
Journal:  Rev Chil Pediatr       Date:  2015-11-21

6.  Demographic characteristics and distribution of lysosomal storage disorder subtypes in Eastern China.

Authors:  Xueru Chen; Wenjuan Qiu; Jun Ye; Lianshu Han; Xuefan Gu; Huiwen Zhang
Journal:  J Hum Genet       Date:  2016-01-07       Impact factor: 3.172

7.  Mucopolysacccharidoses: From understanding to treatment, a century of discoveries.

Authors:  Roberto Giugliani
Journal:  Genet Mol Biol       Date:  2012-12-18       Impact factor: 1.771

8.  Neonatal screening for four lysosomal storage diseases with a digital microfluidics platform: Initial results in Brazil.

Authors:  Eurico Camargo Neto; Jaqueline Schulte; Jamile Pereira; Heydy Bravo; Claudio Sampaio-Filho; Roberto Giugliani
Journal:  Genet Mol Biol       Date:  2018-06-04       Impact factor: 1.771

Review 9.  Diagnostic and treatment strategies in mucopolysaccharidosis VI.

Authors:  Filippo Vairo; Andressa Federhen; Guilherme Baldo; Mariluce Riegel; Maira Burin; Sandra Leistner-Segal; Roberto Giugliani
Journal:  Appl Clin Genet       Date:  2015-10-30

Review 10.  Rare disease landscape in Brazil: report of a successful experience in inborn errors of metabolism.

Authors:  Roberto Giugliani; Filippo P Vairo; Mariluce Riegel; Carolina F M de Souza; Ida V D Schwartz; Sérgio D J Pena
Journal:  Orphanet J Rare Dis       Date:  2016-06-10       Impact factor: 4.123

View more
  4 in total

1.  Mucopolysaccharidoses diagnosis in the era of enzyme replacement therapy in Egypt.

Authors:  Ekram Fateen; Zeinab Y Abdallah; Walaa S Nazim; Mona Ibrahim; Amira Radwan
Journal:  Heliyon       Date:  2021-08-19

Review 2.  Epidemiology of Mucopolysaccharidoses Update.

Authors:  Betul Çelik; Saori C Tomatsu; Shunji Tomatsu; Shaukat A Khan
Journal:  Diagnostics (Basel)       Date:  2021-02-10

Review 3.  Mammalian Sulfatases: Biochemistry, Disease Manifestation, and Therapy.

Authors:  Ryuichi Mashima; Mahito Nakanishi
Journal:  Int J Mol Sci       Date:  2022-07-24       Impact factor: 6.208

Review 4.  Mucopolysaccharidoses and the blood-brain barrier.

Authors:  Onur Sahin; Hannah P Thompson; Grant W Goodman; Jun Li; Akihiko Urayama
Journal:  Fluids Barriers CNS       Date:  2022-09-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.